Both the parties will work together to strenthen the commercial position of Probi brand in the region.
Probi CEO Michael Oredsson said the agreement is an important opportunity to utilize the full potential for Probi Digestis and Probi Defendum in the US.
"Targeted commercial agreements with a range of companies, each with a strong position in their respective sales channel, is required in order to achieve this," Oredsson
"The financial structure of the agreement is transparent and will allow both companies to capture attractive returns."
Viva 5 anticipates launching products containing Probi probiotic strains in the North American market in 2013.